Stimuli-responsive nanotheranostics

Basit Yameen, Jun Wu, Cristian Vilos, Andrew Whyte, David Werstler, Lori Pollit, Omid C. Farokhzad

Resultado de la investigación: Chapter

1 Cita (Scopus)

Resumen

Nanomedicine is emerging as an enabling technology for addressing biomedical related challenges. Encouraging developments have been made particularly in overcoming the limitations associated with the conventional therapeutic and diagnostic agents while treating severe diseases including cancer. Recent research efforts have led to the evolution of nanomedicine from merely performing a therapeutic or diagnostic function to the systems that can perform therapeutic and diagnostic functions simultaneously, referred to as nanotheranostics or theranostics. The theranostic systems are capable of providing real-time feedback on the effectiveness of a particular treatment regimen and can help in adapting the treatment plan at an early stage. The real life impact of a theranostic system can be further augmented by introducing an element of stimuli (endogenous or exogenous) responsive release of the payload. The stimuli responsiveness can enhance the safety and efficacy of a nanomedicine via an on-demand and controlled release of a payload exclusively at the site of action and only when it is deemed necessary, as revealed by the diagnostic feature of the theranostic system. Such a provision of controlled treatment and real-time monitoring is expected to help in adjusting the treatment plan in a personalized manner, particularly, for diseases showing heterogeneity, malignancy, and adaptation. In the present chapter, we provide a comprehensive insight into the biological relevance of stimuli responsive character for developing a theranostic system. We further provide a detailed overview on the recent progress regarding the development of theranostic systems showing responsiveness to a variety of stimuli including pH, temperature, reducing agents, light, magnetic field and enzymes.

Idioma originalEnglish
Título de la publicación alojadaNanotheranostics for Personalized Medicine
EditorialWorld Scientific Publishing Co. Pte Ltd
Páginas267-296
Número de páginas30
ISBN (versión digital)9789814713535
ISBN (versión impresa)9789814713528
DOI
EstadoPublished - 1 abr 2016

Huella dactilar

Medical nanotechnology
Nanomedicine
Reducing Agents
Reducing agents
Therapeutics
Enzymes
Magnetic fields
Feedback
Monitoring
Biomedical Technology
Magnetic Fields
Theranostic Nanomedicine
Neoplasms
Temperature
Safety
Light
Research

ASJC Scopus subject areas

  • Medicine(all)
  • Engineering(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Citar esto

Yameen, B., Wu, J., Vilos, C., Whyte, A., Werstler, D., Pollit, L., & Farokhzad, O. C. (2016). Stimuli-responsive nanotheranostics. En Nanotheranostics for Personalized Medicine (pp. 267-296). World Scientific Publishing Co. Pte Ltd. https://doi.org/10.1142/9741
Yameen, Basit ; Wu, Jun ; Vilos, Cristian ; Whyte, Andrew ; Werstler, David ; Pollit, Lori ; Farokhzad, Omid C. / Stimuli-responsive nanotheranostics. Nanotheranostics for Personalized Medicine. World Scientific Publishing Co. Pte Ltd, 2016. pp. 267-296
@inbook{e222c66abf954785942d4c96547f0f6f,
title = "Stimuli-responsive nanotheranostics",
abstract = "Nanomedicine is emerging as an enabling technology for addressing biomedical related challenges. Encouraging developments have been made particularly in overcoming the limitations associated with the conventional therapeutic and diagnostic agents while treating severe diseases including cancer. Recent research efforts have led to the evolution of nanomedicine from merely performing a therapeutic or diagnostic function to the systems that can perform therapeutic and diagnostic functions simultaneously, referred to as nanotheranostics or theranostics. The theranostic systems are capable of providing real-time feedback on the effectiveness of a particular treatment regimen and can help in adapting the treatment plan at an early stage. The real life impact of a theranostic system can be further augmented by introducing an element of stimuli (endogenous or exogenous) responsive release of the payload. The stimuli responsiveness can enhance the safety and efficacy of a nanomedicine via an on-demand and controlled release of a payload exclusively at the site of action and only when it is deemed necessary, as revealed by the diagnostic feature of the theranostic system. Such a provision of controlled treatment and real-time monitoring is expected to help in adjusting the treatment plan in a personalized manner, particularly, for diseases showing heterogeneity, malignancy, and adaptation. In the present chapter, we provide a comprehensive insight into the biological relevance of stimuli responsive character for developing a theranostic system. We further provide a detailed overview on the recent progress regarding the development of theranostic systems showing responsiveness to a variety of stimuli including pH, temperature, reducing agents, light, magnetic field and enzymes.",
author = "Basit Yameen and Jun Wu and Cristian Vilos and Andrew Whyte and David Werstler and Lori Pollit and Farokhzad, {Omid C.}",
year = "2016",
month = "4",
day = "1",
doi = "10.1142/9741",
language = "English",
isbn = "9789814713528",
pages = "267--296",
booktitle = "Nanotheranostics for Personalized Medicine",
publisher = "World Scientific Publishing Co. Pte Ltd",

}

Yameen, B, Wu, J, Vilos, C, Whyte, A, Werstler, D, Pollit, L & Farokhzad, OC 2016, Stimuli-responsive nanotheranostics. En Nanotheranostics for Personalized Medicine. World Scientific Publishing Co. Pte Ltd, pp. 267-296. https://doi.org/10.1142/9741

Stimuli-responsive nanotheranostics. / Yameen, Basit; Wu, Jun; Vilos, Cristian; Whyte, Andrew; Werstler, David; Pollit, Lori; Farokhzad, Omid C.

Nanotheranostics for Personalized Medicine. World Scientific Publishing Co. Pte Ltd, 2016. p. 267-296.

Resultado de la investigación: Chapter

TY - CHAP

T1 - Stimuli-responsive nanotheranostics

AU - Yameen, Basit

AU - Wu, Jun

AU - Vilos, Cristian

AU - Whyte, Andrew

AU - Werstler, David

AU - Pollit, Lori

AU - Farokhzad, Omid C.

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Nanomedicine is emerging as an enabling technology for addressing biomedical related challenges. Encouraging developments have been made particularly in overcoming the limitations associated with the conventional therapeutic and diagnostic agents while treating severe diseases including cancer. Recent research efforts have led to the evolution of nanomedicine from merely performing a therapeutic or diagnostic function to the systems that can perform therapeutic and diagnostic functions simultaneously, referred to as nanotheranostics or theranostics. The theranostic systems are capable of providing real-time feedback on the effectiveness of a particular treatment regimen and can help in adapting the treatment plan at an early stage. The real life impact of a theranostic system can be further augmented by introducing an element of stimuli (endogenous or exogenous) responsive release of the payload. The stimuli responsiveness can enhance the safety and efficacy of a nanomedicine via an on-demand and controlled release of a payload exclusively at the site of action and only when it is deemed necessary, as revealed by the diagnostic feature of the theranostic system. Such a provision of controlled treatment and real-time monitoring is expected to help in adjusting the treatment plan in a personalized manner, particularly, for diseases showing heterogeneity, malignancy, and adaptation. In the present chapter, we provide a comprehensive insight into the biological relevance of stimuli responsive character for developing a theranostic system. We further provide a detailed overview on the recent progress regarding the development of theranostic systems showing responsiveness to a variety of stimuli including pH, temperature, reducing agents, light, magnetic field and enzymes.

AB - Nanomedicine is emerging as an enabling technology for addressing biomedical related challenges. Encouraging developments have been made particularly in overcoming the limitations associated with the conventional therapeutic and diagnostic agents while treating severe diseases including cancer. Recent research efforts have led to the evolution of nanomedicine from merely performing a therapeutic or diagnostic function to the systems that can perform therapeutic and diagnostic functions simultaneously, referred to as nanotheranostics or theranostics. The theranostic systems are capable of providing real-time feedback on the effectiveness of a particular treatment regimen and can help in adapting the treatment plan at an early stage. The real life impact of a theranostic system can be further augmented by introducing an element of stimuli (endogenous or exogenous) responsive release of the payload. The stimuli responsiveness can enhance the safety and efficacy of a nanomedicine via an on-demand and controlled release of a payload exclusively at the site of action and only when it is deemed necessary, as revealed by the diagnostic feature of the theranostic system. Such a provision of controlled treatment and real-time monitoring is expected to help in adjusting the treatment plan in a personalized manner, particularly, for diseases showing heterogeneity, malignancy, and adaptation. In the present chapter, we provide a comprehensive insight into the biological relevance of stimuli responsive character for developing a theranostic system. We further provide a detailed overview on the recent progress regarding the development of theranostic systems showing responsiveness to a variety of stimuli including pH, temperature, reducing agents, light, magnetic field and enzymes.

UR - http://www.scopus.com/inward/record.url?scp=85018837665&partnerID=8YFLogxK

U2 - 10.1142/9741

DO - 10.1142/9741

M3 - Chapter

SN - 9789814713528

SP - 267

EP - 296

BT - Nanotheranostics for Personalized Medicine

PB - World Scientific Publishing Co. Pte Ltd

ER -

Yameen B, Wu J, Vilos C, Whyte A, Werstler D, Pollit L y otros. Stimuli-responsive nanotheranostics. En Nanotheranostics for Personalized Medicine. World Scientific Publishing Co. Pte Ltd. 2016. p. 267-296 https://doi.org/10.1142/9741